메뉴 건너뛰기
Blood
Volumn 122, Issue 20, 2013, Pages 3397-3398
In the spotlight: A novel CD37 antibody-drug conjugate
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; CD37 ANTIGEN; IMGN 529; RITUXIMAB; UNCLASSIFIED DRUG;
EID: 84888233707     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-09-526384     Document Type: Review
Times cited : (4)
References (8)
  • 1
    • 84888250428 scopus 로고    scopus 로고
    • A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies
    • Deckert J, Park PU, Chicklas S, et al. A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies. Blood. 2013;122(20):3500-3510.
    • (2013) Blood , vol.122 , Issue.20 , pp. 3500-3510
    • Deckert, J.1    Park, P.U.2    Chicklas, S.3
  • 2
    • 0023870925 scopus 로고
    • The B cell-associated CD37 antigen (gp40-52). Structure and subcellular expression of an extensively glycosylated glycoprotein
    • Schwartz-Albiez R, Dörken B, Hofmann W, Moldenhauer G. The B cell-associated CD37 antigen (gp40-52). Structure and subcellular expression of an extensively glycosylated glycoprotein. J Immunol. 1988;140(3):905-914.
    • (1988) J Immunol. , vol.140 , Issue.3 , pp. 905-914
    • Schwartz-Albiez, R.1    Dörken, B.2    Hofmann, W.3    Moldenhauer, G.4
  • 3
    • 0024321013 scopus 로고
    • Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody
    • Press OW, Eary JF, Badger CC, et al. Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol. 1989;7(8):1027-1038.
    • (1989) J Clin Oncol. , vol.7 , Issue.8 , pp. 1027-1038
    • Press, O.W.1    Eary, J.F.2    Badger, C.C.3
  • 4
    • 34948858867 scopus 로고    scopus 로고
    • Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical
    • Zhao X, Lapalombella R, Joshi T, et al. Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood. 2007;110(7):2569-2577.
    • (2007) Blood , vol.110 , Issue.7 , pp. 2569-2577
    • Zhao, X.1    Lapalombella, R.2    Joshi, T.3
  • 5
    • 80054115014 scopus 로고    scopus 로고
    • A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies
    • Heider K-H, Kiefer K, Zenz T, et al. A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies. Blood. 2011;118(15):4159-4168.
    • (2011) Blood , vol.118 , Issue.15 , pp. 4159-4168
    • Heider, K.-H.1    Kiefer, K.2    Zenz, T.3
  • 6
    • 84873027242 scopus 로고    scopus 로고
    • Evaluating antigen targeting and anti-tumor activity of a new anti-CD37 radioimmunoconjugate against non-Hodgkin's lymphoma
    • Dahle J, Repetto-Llamazares AH, Mollatt CS, et al. Evaluating antigen targeting and anti-tumor activity of a new anti-CD37 radioimmunoconjugate against non-Hodgkin's lymphoma. Anticancer Res. 2013;33(1):85-95.
    • (2013) Anticancer Res. , vol.33 , Issue.1 , pp. 85-95
    • Dahle, J.1    Repetto-Llamazares, A.H.2    Mollatt, C.S.3
  • 7
    • 80054117546 scopus 로고    scopus 로고
    • Brentuximab vedotin (SGN-35)
    • Katz J, Janik JE, Younes A. Brentuximab vedotin (SGN-35). Clin Cancer Res. 2011;17(20):6428-6436.
    • (2011) Clin Cancer Res. , vol.17 , Issue.20 , pp. 6428-6436
    • Katz, J.1    Janik, J.E.2    Younes, A.3
  • 8
    • 80054092983 scopus 로고    scopus 로고
    • Trastuzumab emtansine: A unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer
    • LoRusso PM, Weiss D, Guardino E, Girish S, Sliwkowski MX. Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer. Clin Cancer Res. 2011;17(20):6437- 6447.
    • (2011) Clin Cancer Res. , vol.17 , Issue.20 , pp. 6437-6447
    • LoRusso, P.M.1    Weiss, D.2    Guardino, E.3    Girish, S.4    Sliwkowski, M.X.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.